Your browser doesn't support javascript.
loading
Outcome quality standards in advanced ovarian cancer surgery.
Llueca, Antoni; Serra, Anna; Climent, Maria Teresa; Segarra, Blanca; Maazouzi, Yasmine; Soriano, Marta; Escrig, Javier.
Afiliação
  • Llueca A; Department of Obstetrics and Gynecology, University General Hospital of Castellón, Av Benicasim s/n, 12004, Castellón, Spain. antonillueca@gmail.com.
  • Serra A; Multidisciplinary Unit of Abdominal Pelvic Oncology Surgery (MUAPOS), University General Hospital of Castellón, Av Benicasim s/n, 12004, Castellón, Spain. antonillueca@gmail.com.
  • Climent MT; Department of Medicine, University Jaume I (UJI), Castellón, Spain. antonillueca@gmail.com.
  • Segarra B; Department of Obstetrics and Gynecology, University General Hospital of Castellón, Av Benicasim s/n, 12004, Castellón, Spain.
  • Maazouzi Y; Multidisciplinary Unit of Abdominal Pelvic Oncology Surgery (MUAPOS), University General Hospital of Castellón, Av Benicasim s/n, 12004, Castellón, Spain.
  • Soriano M; Department of Medicine, University Jaume I (UJI), Castellón, Spain.
  • Escrig J; Department of Obstetrics and Gynecology, University General Hospital of Castellón, Av Benicasim s/n, 12004, Castellón, Spain.
World J Surg Oncol ; 18(1): 309, 2020 Nov 25.
Article em En | MEDLINE | ID: mdl-33239057
ABSTRACT

INTRODUCTION:

Advanced ovarian cancer surgery (AOCS) frequently results in serious postoperative complications. Because managing AOCS is difficult, some standards need to be established that allow surgeons to assess the quality of treatment provided and consider what aspects should improve. This study aimed to identify quality indicators (QIs) of clinical relevance and to establish their acceptable quality limits (i.e., standard) in AOCS. MATERIALS AND

METHODS:

We performed a systematic search on clinical practice guidelines, consensus conferences, and reviews on the outcome and quality of AOCS to identify which QIs have clinical relevance in AOCS. We then searched the literature (from January 2006 to December 2018) for each QI in combination with the keywords of advanced ovarian cancer, surgery, outcome, and oncology. Standards for each QI were determined by statistical process control techniques. The acceptable quality limits for each QI were defined as being within the limits of the 99.8% interval, which indicated a favorable outcome.

RESULTS:

A total of 38 studies were included. The QIs selected for AOCS were complete removal of the tumor upon visual inspection (complete cytoreductive surgery), a residual tumor of < 1 cm (optimal cytoreductive surgery), a residual tumor of > 1 cm (suboptimal cytoreductive surgery), major morbidity, and 5-year survival. The rates of complete cytoreductive surgery, optimal cytoreductive surgery, suboptimal cytoreductive surgery, morbidity, and 5-year survival had quality limits of < 27%, < 23%, > 39%, > 33%, and < 27%, respectively.

CONCLUSION:

Our results provide a general view of clinical indicators for AOCS. Acceptable quality limits that can be considered as standards were established.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Tipo de estudo: Guideline / Prognostic_studies Limite: Female / Humans Idioma: En Revista: World J Surg Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Tipo de estudo: Guideline / Prognostic_studies Limite: Female / Humans Idioma: En Revista: World J Surg Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha